Nordson Other Income (Expense) decreased by 149.9% to -$10.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 65.3%, from -$29.98M to -$10.40M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 29.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$10.53M | -$7.88M | -$11.33M | -$3.89M | -$44.71M | -$4.41M | -$69.00K | -$13.14M | -$10.88M | -$8.94M | -$24.46M | -$20.74M | -$19.34M | -$17.62M | -$30.82M | -$24.09M | -$29.98M | -$28.64M | -$31.36M | $20.84M | -$10.40M |
| QoQ Change | — | +25.2% | -43.7% | +65.6% | <-999% | +90.1% | +98.4% | <-999% | +17.2% | +17.8% | -173.5% | +15.2% | +6.7% | +8.9% | -74.9% | +21.8% | -24.4% | +4.5% | -9.5% | +166.4% | -149.9% |
| YoY Change | — | — | — | — | -324.4% | +44.0% | +99.4% | -237.5% | +75.7% | -102.7% | <-999% | -57.8% | -77.8% | -97.0% | -26.0% | -16.2% | -55.0% | -62.5% | -1.8% | +186.5% | +65.3% |